MELE Melexis NV

Melexis: update over het aandeleninkoopprogramma

Melexis: update over het aandeleninkoopprogramma

Persbericht - Gereglementeerde informatie



Ieper, België – 16 juni 2025, 17.45 uur CET

Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 2.624 eigen aandelen ingekocht werden op Euronext Brussel tussen 9 en 13 juni 2025.

InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)
9/6/20251.97264,7164,3565,00127.614
10/6/20250----
11/6/20250----
12/6/20250----
13/6/202565265,0065,0065,0042.380
TOTAAL2.62464,7864,3565,00169.994

Als gevolg van aankopen die zijn gedaan sinds de lancering van het aandeleninkoopprogramma voor maximaal 850.000 aandelen, heeft Melexis nu 480.782 eigen aandelen in bezit.





EN
16/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Melexis NV

Pierre FerraguÊ
  • Pierre FerraguÊ

Bible 2Q25 – Autos: Semi recovery underway; tangible risks of pull-for...

Today, we are publishing the Autos section of our 28th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Hyperscale & Cloud, Telecom Equipment, PCs, Enterprise IT, Foundry and Semicap Equipment. The auto semiconductor recovery is underway, with revenues up 4% QoQ ...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Melexis/Slow cyclical recovery/HOLD

Melexis reported a mixed 2Q25 update with the early signs of a market recovery but at the same time disappointing gross margins. We believe that automotive semiconductors will recover further from current lows, but we also expect ongoing uncertainty and low visibility given the major ongoing changes in the auto sector and tariff discussions We reiterate our HOLD rating but increase our target price from €60 to €70 per share given the early signs of an uptrend.

Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri

ResearchPool Subscriptions

Get the most out of your insights

Get in touch